Latest debt-to-equity ratio
Neuphoria Therapeutics Debt-to-equity ratio
Direct answer
Neuphoria Therapeutics's debt-to-equity ratio is 0.12%.
The verified market snapshot reports 0.12%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 17, 2026.
Get free Neuphoria Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 0.12%
Explore related company data
View Neuphoria Therapeutics's market capitalizationView Neuphoria Therapeutics's price-to-book ratioView Neuphoria Therapeutics's return on equityView Neuphoria Therapeutics's 52-week price rangeView Neuphoria Therapeutics's profit marginView all Neuphoria Therapeutics key metricsReturn to Neuphoria Therapeutics profile